Form 13-F position report

TELOMIR PHARMACEUTICALS INC

Reported by VANGUARD GROUP INC

TELO CUSIP 87975F104 Manager CIK 0000102909

Reported 1,268,754 shares, up 117,227 (10.2%) from the prior quarter.

Reported value -29.3%; share count 10.2% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q4 2024
Shares 1,268,754 Quarter-end amount reported
Reported value $5,227,266 Fair value at quarter end
Consecutive quarters held 3 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-06-30 137951
2024-09-30 7392804
2024-12-31 5227266
2025-03-31 4063954
2025-06-30 1397783
2025-09-30 1531435
2025-12-31 1512830

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for TELOMIR PHARMACEUTICALS INC held by VANGUARD GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Added 1,137,466 +35,714 (3.2%) < 0.01% $1,512,830 2026-01-29
Q3 2025 Reduced 1,101,752 -16,474 (-1.5%) < 0.01% $1,531,435 2025-11-07
Q2 2025 Reduced 1,118,226 -139,964 (-11.1%) < 0.01% $1,397,783 2025-08-11
Q1 2025 Reduced 1,258,190 -10,564 (-0.8%) < 0.01% $4,063,954 2025-05-09
Q4 2024 Added 1,268,754 +117,227 (10.2%) < 0.01% $5,227,266 2025-02-11
Q3 2024 Added 1,151,527 +1,122,847 (3915.1%) < 0.01% $7,392,804 2024-11-13
Q2 2024 New 28,680 +28,680 (0.0%) < 0.01% $137,951 2024-08-13

Who else reported the position

42 managers reported TELOMIR PHARMACEUTICALS INC for Q4 2024.

Managers reporting TELOMIR PHARMACEUTICALS INC in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC This report Added 1,268,754 +117,227 < 0.01% $5,227,266 3 qtrs
BlackRock Inc Added 1,056,975 +690,097 < 0.01% $4,354,738 2 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 413,677 +174,940 < 0.01% $1,704,857 3 qtrs
NORTHERN TRUST CORPORATION Added 151,628 +102,948 < 0.01% $624,707 2 qtrs
STATE STREET CORPORATION Added 115,794 +79,700 < 0.01% $477,071 3 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 72,295 +20,931 < 0.01% $297,856 3 qtrs
Gotham Asset Management LLC New 6,770 +6,770 < 0.01% $228,555 1 qtr
Suncoast Equity Management Unchanged 51,194 0 0.02% $210,919 4 qtrs
The Goldman Sachs Group Inc New 50,530 +50,530 < 0.01% $208,184 1 qtr
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 46,406 +35,556 < 0.01% $191,193 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 11, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
21,657
None
1,247,097

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.